Gallbladder Cholesterolosis, Body Mass Index and Serum Cholesterol and Triglycerides
NCT ID: NCT00528632
Last Updated: 2011-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
406 participants
OBSERVATIONAL
2008-03-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To the best of the investigators knowledge no study has analyzed the relationships of Body Mass Index, serum Cholesterol and Triglycerides and gallbladder cholesterolosis.
The purpose of this study is to analyze and find relations between gallbladder cholesterolosis, Body Mass Index, serum cholesterol and triglycerides.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contrastive Study for Minimally Invasive Cholecystolithotomy With Gallbladder Reservation and Laparoscopic Cholecystectomy
NCT01822262
Sleeve Gastrectomy and Cholecystectomy Are Safe in Obese Patients With Asymptomatic Cholelithiasis
NCT04878640
Post-ERCP Cholecystectomy. How ERCP and ERCP-related Variables Effect the Outcomes?
NCT06388525
Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy
NCT02956252
Common Bile Duct Pressure After Surgical Exploration
NCT04968873
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Age
* Gender
* Diagnosis
* Weight
* Height
* Body Mass Index
* Histopathological results (Biopsy)
* Serum cholesterol
* Serum triglycerides
All elective patients older than 15 years of age submitted to cholecystectomy for symptomatic gallstones were included. Plasma cholesterol and triglycerides levels were measured 5 to 7 days before surgery. Only patients with chronic cholecystitis and with cholesterolosis according to the histology of the surgical specimen were included, we did not include any patient with acute cholecystitis or gallbladder cancer.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cholesterolosis
I. Patients with gallbladder cholesterolosis and symptomatic cholelithiasis
Specimen biopsy and serum laboratory tests
Biopsy of the surgical specimens (gallbladder) submitted after cholecystectomy
Laboratory tests measuring levels of plasma total cholesterol and triglycerides
Cholelithiasis
II. Patients without gallbladder cholesterolosis and with symptomatic cholelithiasis
Specimen biopsy and serum laboratory tests
Biopsy of the surgical specimens (gallbladder) submitted after cholecystectomy
Laboratory tests measuring levels of plasma total cholesterol and triglycerides
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Specimen biopsy and serum laboratory tests
Biopsy of the surgical specimens (gallbladder) submitted after cholecystectomy
Laboratory tests measuring levels of plasma total cholesterol and triglycerides
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histopathological report of gallbladder cholesterolosis
* Histopathological report of chronic cholecystitis
* Patients older than 15 years of age
Exclusion Criteria
* Pathological report missing from the hospital records
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cirujanos la Serena
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital De La Serena
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcelo A Beltran, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital de La Serena
Carlos Barria, MD
Role: STUDY_DIRECTOR
Hospital De La Serena - HISTOMED
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital De La Serena
La Serena, Coquimbo Region, Chile
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HLS-0012-09-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.